Lamberts, Laetitia E; Koch, Maximillian; de Jong, Johannes S; Adams, Arthur; Glatz, Juergen; Kranendonk, Marriette E G; Terwisscha van Scheltinga, Anton G T; Jansen, Liesbeth; de Vries, Jakob; Lub-de Hooge, Marjolijn N; Schroder, Carolien P; Jorritsma-Smit, Annelies; Linssen, Matthijs D; de Boer, Esther; van der Vegt, Bert; Nagengast, Wouter B; Elias, Sjoerd G; Oliveira, Sabrina; Witkamp, Arjen; Mali, Willem P Th M; van der Wall, Elsken; Van Diest, Paul J; de Vries, Elisabeth G; Ntziachristos, Vasilis; van Dam, Gooitzen M
(American Association for Cancer Research Inc., 2017-06)
Purpose: To provide proof of principle of safety, breast tumor-specific uptake, and positive tumor margin assessment of the systemically administered near-infrared fluorescent tracer bevacizumab-IRDye800CWtargeting VEGF-A ...